Valuation: OrganiGram Holdings Inc

Market Cap 241M 175M 149M 140M 128M 16.7B 245M 1.65B 644M 8.4B 656M 641M 27.75B P/E 2026 *
2.06x
P/E 2027 * 20.8x
Enterprise Value 241M 175M 149M 140M 128M 16.7B 245M 1.65B 644M 8.4B 656M 641M 27.75B EV / Sales 2026 *
0.69x
EV / Sales 2027 * 0.53x
Free-Float
69.79%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 2026-01-14
Director of Finance/CFO - 2024-01-07
Chief Operating Officer - 2026-08-18
Director TitleAgeSince
Chairman 65 2018-03-28
Director/Board Member 56 2018-12-16
Director/Board Member 70 2018-12-16
Change 5-day change 1-year change 3-year change Capi.($)
+4.72%+2.95% - - 174M
-1.53%+2.39%-6.20%+173.40% 319M
-2.92%-6.74%-20.57%-19.02% 174M
+1.02%+1.02%+4.76%+88.57% 140M
+6.98%+12.20%-23.33%-19.30% 87.38M
+5.36%+9.26%+15.69%+34.09% 50.18M
Average +2.27%+0.51%-5.93%+51.55% 154.21M
Weighted average by Cap. +0.90%+0.86%-7.97%+83.61%

Financials

2026 *2027 *
Net sales 350M 254M 217M 203M 186M 24.27B 357M 2.4B 936M 12.2B 953M 932M 40.33B 458M 332M 284M 266M 244M 31.79B 467M 3.15B 1.23B 15.98B 1.25B 1.22B 52.81B
Net income 128M 93.04M 79.67M 74.45M 68.26M 8.9B 131M 882M 343M 4.48B 350M 342M 14.79B 8.1M 5.87M 5.03M 4.7M 4.31M 562M 8.26M 55.68M 21.68M 283M 22.06M 21.58M 934M
Net Debt - -
Logo OrganiGram Holdings Inc
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-